8:30 – 10:30 am – “Cannabis and CBD in 2023”
Cannabis policies are constantly changing. Many of our patients are either interested in using cannabis
or cannabinoids or are already doing so. In this seminar, Dr. Hill will review the evidence for both the
risks and the benefits of cannabis and cannabinoids like CBD so that healthcare professionals can help
patients make more informed choices about using these complex substances.
1. To review some of the basic risks associated with cannabis use.
2. To discuss the current state of the evidence for the therapeutic use of cannabis.
3. To describe potential side effects of CBD.
Speaker: Kevin P. Hill, MD, Beth Isreal Deaconess Medical Center, Harvard Medical School
10:30 – 10:45 am Break
10:45 – 11:45 am “Medical Management of Hypersexual Behaviors”
Hypersexual behaviors are not uncommon in psychiatric clinical settings. In this presentation, Dr.
Stanislaus will discuss the role of hormones and neurotransmitters in sexual behaviors, the medications
that have clinical utility in managing hypersexual behaviors and their pharmacological actions.
1. Understand the role of sex hormones and neurotransmitters in sexual functioning.
2. Understand the role of medications in managing hypersexual behaviors.
3. Learn the mechanism of action of the various classes of medications in decreasing hypersexual
Speaker: Angeline Stanislaus, MD, Forensic Psychiatrist, Chief Medical Officer, Missouri Department of
11:45 – 12:00 noon Break
12:00 – 1:00 pm “Psychedelics 102: Psychedelic-Assisted Psychotherapy”
The presentation will cover a brief history of psychedelics in America, how we got to this point in
research and clinical use, concepts of neuroplasticity and synaptogenesis, elements of psychedelicassisted psychotherapy and how they differ from traditional psychotherapy.
1. Know the difference between traditional and psychedelic-assisted psychotherapy.
2. Know the basic categories of psychedelics currently being studied and used clinically.
3. Know who may be appropriate for this type of therapy.
Speaker: Larry Shapiro, PhD, Quantum Behavioral, LLC, Washington University School of Medicine
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Center for Behavioral Medicine and Missouri Psychiatric Physicians Association. The Center for Behavioral Medicine is accredited by the ACCME to provide continuing medical education for physicians. Any Physician attending the entire Missouri Psychiatric Physicians Association Virtual Spring Educational Webinar on Saturday, May 6, 2023, will be awarded 4.0 AMA PRA Category 1 Credit(s). For every 1 hour subject the attendee will receive 1 AMA PRA credit.
Virtual attendees will be sent an email within a week before the conference with a Zoom link, be sure to set up a Zoom account prior to the seminar. The seminar will start at 8:30 am, with two short breaks. All sessions will be live streamed and handouts for the conference will be sent ahead of time to the email provided above. Be sure that your name is listed on your Zoom account to ensure check-in. MPPA is not responsible for your inability to connect and attend if your device or Internet connection are inadequate.
Please fill out and submit to:
722 E. Capitol Avenue
Jefferson City, MO 65101